Volume 5 Issue 2, Jun 2020

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 5 Issue 2, Jun 2020:
Editorial
Novel targeted drugs approved by the NMPA and FDA in 2019
Wenjing Wang &Qiu Sun